1 April 2023 false No description of principal activity Taxfiler 2024.5 11888796business:PrivateLimitedCompanyLtd2023-04-012024-03-31 118887962023-03-31 118887962023-04-012024-03-31 11888796business:AuditExempt-NoAccountantsReport2023-04-012024-03-31 11888796business:FilletedAccounts2023-04-012024-03-31 118887962024-03-31 11888796business:Director12023-04-012024-03-31 11888796business:RegisteredOffice2023-04-012024-03-31 118887962023-03-31 11888796core:WithinOneYear2024-03-31 11888796core:WithinOneYear2023-03-31 11888796core:ShareCapitalcore:PreviouslyStatedAmount2024-03-31 11888796core:ShareCapitalcore:PreviouslyStatedAmount2023-03-31 11888796core:PreviouslyStatedAmount2024-03-31 11888796core:PreviouslyStatedAmount2023-03-31 11888796business:SmallEntities2023-04-012024-03-31 11888796countries:EnglandWales2023-04-012024-03-31 118887962022-04-012023-03-31 iso4217:GBP xbrli:pure
Company Registration No. 11888796 (England and Wales)
NAZ MPHARM LTD Unaudited accounts for the year ended 31 March 2024
NAZ MPHARM LTD Unaudited accounts Contents
Page
- 2 -
NAZ MPHARM LTD Company Information for the year ended 31 March 2024
Director
Nazma Bibi
Company Number
11888796 (England and Wales)
Registered Office
199 Great Norbury Street, Hyde SK14 1HU
Accountants
PRIME ACCOUNTANTS 10 LOCKWOOD HOUSE LOCKWOOD PARK HUDDERSFIELD HD4 6EN
- 3 -
NAZ MPHARM LTD Statement of financial position as at 31 March 2024
2024 
2023 
Notes
£ 
£ 
Current assets
Cash at bank and in hand
57,987 
41,787 
Creditors: amounts falling due within one year
(57,986)
(41,786)
Net current assets
1 
1 
Net assets
1 
1 
Capital and reserves
Called up share capital
1 
1 
Shareholders' funds
1 
1 
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 September 2024 and were signed on its behalf by
Nazma Bibi Director Company Registration No. 11888796
- 4 -
NAZ MPHARM LTD Notes to the Accounts for the year ended 31 March 2024
1
Statutory information
NAZ MPHARM LTD is a private company, limited by shares, registered in England and Wales, registration number 11888796. The registered office is 199 Great Norbury Street, , Hyde, SK14 1HU.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
4
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
Taxes and social security
560 
212 
Loans from directors
57,426 
41,574 
57,986 
41,786 
5
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 5 -